Moneycontrol
Get App
you are here: HomeNewsIndia
Last Updated : Mar 28, 2020 06:38 PM IST | Source: PTI

Coronavirus pandemic | Sun Pharma commits Rs 25 cr worth of drugs, sanitisers to fight COVID-19

"The company is committed to working closely with the governments and relevant stakeholders to ensure that there is uninterrupted supply of medicines," Sun Pharma said in a statement.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sun Pharmaceutical Industries will donate Rs 25 crore worth of Hydroxychloroquine (HCQS), Azithromycin, other related drugs and hand sanitisers to support India's fight against COVID-19, according to a company statement.

The national task force for COVID-19 has recommended the prophylactic use of HCQS for high risk population. HCQS is being studied by the World Health Organization (WHO) for use in conjunction with Azithromycin to treat COVID-19, it added.

"The company is committed to working closely with the governments and relevant stakeholders to ensure that there is uninterrupted supply of medicines," Sun Pharma said in a statement.

Close

The company is constituting a task force to handle the distribution of these products in India, it added.

Commending the efforts of the entire medical and support fraternity in fighting COVID-19, Sun Pharma said," To help these front-line warriors, the company has repurposed its liquid manufacturing facility in India to produce high-quality hand sanitisers".

These will be made available to healthcare professionals serving their communities and the nation, it added.

In a related development, the company's arm Sun Pharmaceutical Industries, Inc USA  said it has donated 2.5 million hydroxychloroquine sulfate tablets for use in the US.

The company is seeking to enable healthcare experts meet the growing patient demands for this product as they assess its potential to treat COVID-19 through clinical trials, it said in a statement.

" At Sun Pharma, we are resolute in our purpose to help people live healthier lives and stand united in our global fight against COVID-19," Sun Pharma, North America CEO Abhay Gandhi said.

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

Get best insights into Options Trading. Webinar by Mr. Vishal B Malkan is Live. Watch Now!

First Published on Mar 28, 2020 06:27 pm